Icon

LOTEMAX (nda020583)- (0.5%)

LOTEPREDNOL ETABONATE BAUSCH AND LOMB
0.5%
No No
2014-Apr-25 Expired
None None
None No
LOTEMAX is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation.
3 0 2
Total Other Developers 2
Drugs with Suitability No
0.5% ** ** Up - 2
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ***** ********* ******* *** (*** *****) *********** *** ******* ******, **********, *** **** (**) *****, ****** ****** (***) ***
****** ******* ********** ** *********** ************** *, **********, ****, *********** (***) ***
****** *** ***** *** ************** ******** ******* *********** ****** **. ** *** ** - ******* :- ***** **** - *****, ***** **********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.